Prostacyclin-analog therapy in sickle cell pulmonary hypertension.

Sickle cell disease (SCD) is associated with pulmonary hypertension (PH) which results in high morbidity and mortality.[1][1] There are well-established therapies for pulmonary arterial hypertension (PAH), but few reports about their use in SCDPH.[2][2] We report the clinical course of 11 SCDPH